Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
EA
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.2% |
| 2 | Technology | 14.19% |
| 3 | Financials | 12.33% |
| 4 | Consumer Staples | 10.22% |
| 5 | Industrials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IIN
2351
DELISTED
IntriCon Corporation
IIN
| $1.65M | ﹤0.01% |
201,899
+17,000
| +9% | +$142K |
|
|
EHIC
2352
DELISTED
eHi Car Services Limited
EHIC
| $1.65M | ﹤0.01% |
165,200
+4,300
| +3% | +$43.1K |
|
2353
Biglari Holdings Class B
BH
$1.21B
| $1.65M | ﹤0.01% |
6,180
-4,710
| -43% | -$1.29M |
|
2354
OR Royalties Inc
OR
$6.17B
| $1.64M | ﹤0.01% |
+134,174
| New | +$1.52M |
|
|
SORL
2355
DELISTED
SORL Auto Parts, Inc.
SORL
| $1.64M | ﹤0.01% |
245,500
+201,800
| +462% | +$1.2M |
|
|
PRSS
2356
DELISTED
CafePress Inc.
PRSS
| $1.64M | ﹤0.01% |
660,700
+70,700
| +12% | +$189K |
|
|
SUNE
2357
SUNation Energy
SUNE
$10.3M
| $1.64M | ﹤0.01% |
1
| – | – |
|
|
HMHC
2358
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $1.63M | ﹤0.01% |
132,500
-918,300
| -87% | -$11.2M |
|
|
KTEC
2359
DELISTED
Key Technology Inc
KTEC
| $1.63M | ﹤0.01% |
118,400
+10,111
| +9% | +$132K |
|
|
KWY
2360
Kingsway Corp
KWY
$284M
| $1.63M | ﹤0.01% |
268,900
-18,000
| -6% | -$108K |
|
2361
Addus HomeCare
ADUS
$2.18B
| $1.62M | ﹤0.01% |
43,600
-13,400
| -24% | -$482K |
|
2362
Dorchester Minerals
DMLP
$1.37B
| $1.62M | ﹤0.01% |
112,252
+46,379
| +70% | +$756K |
|
|
CNXM
2363
DELISTED
CNX Midstream Partners LP
CNXM
| $1.62M | ﹤0.01% |
85,600
-93,200
| -52% | -$1.95M |
|
|
DCP
2364
DELISTED
DCP Midstream, LP
DCP
| $1.62M | ﹤0.01% |
+47,810
| New | +$1.7M |
|
|
NBLX
2365
DELISTED
Noble Midstream Partners LP
NBLX
| $1.62M | ﹤0.01% |
+35,625
| New | +$1.69M |
|
|
CVRR
2366
DELISTED
CVR Refining, LP
CVRR
| $1.61M | ﹤0.01% |
+169,700
| New | +$1.63M |
|
|
GST
2367
DELISTED
Gastar Exploration Inc.
GST
| $1.61M | ﹤0.01% |
1,740,874
+219,400
| +14% | +$263K |
|
|
TST
2368
DELISTED
TheStreet, Inc.
TST
| $1.61M | ﹤0.01% |
194,121
+19,811
| +11% | +$168K |
|
|
CEA
2369
DELISTED
China Eastern Airlines
CEA
| $1.61M | ﹤0.01% |
52,600
-200
| -0.4% | -$5.69K |
|
2370
Simpson Manufacturing
SSD
$7.91B
| $1.61M | ﹤0.01% |
36,800
-51,100
| -58% | -$2.14M |
|
|
MSON
2371
DELISTED
Misonix Inc
MSON
| $1.6M | ﹤0.01% |
167,800
+1,200
| +0.7% | +$12.5K |
|
2372
Ameresco
AMRC
$1.49B
| $1.6M | ﹤0.01% |
207,600
+1,345
| +0.7% | +$9.03K |
|
|
CRESY
2373
Cresud
CRESY
$743M
| $1.59M | ﹤0.01% |
91,399
+22,448
| +33% | +$410K |
|
2374
Kewaunee Scientific
KEQU
$105M
| $1.59M | ﹤0.01% |
63,900
+4,700
| +8% | +$109K |
|
|
PBT
2375
Permian Basin Royalty Trust
PBT
$1.59B
| $1.59M | ﹤0.01% |
182,801
+90,374
| +98% | +$863K |
|
Similar funds
Jim Simons's Q2 2017 Portfolio in Review
As of Q2 2017, Jim Simons held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Jim Simons deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Jim Simons's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Jim Simons added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Jim Simons's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Jim Simons fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Jim Simons's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Jim Simons opened 398 new positions and closed 418 in Q2 2017.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.